One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights page
doi : 10.1016/S0360-3016(23)07865-3
Volume 117, Issue 4, 15 November 2023, Pages A9-A11
The Internal Mammary Node Irradiation Debate in Node-Positive Breast Cancer: Case Closed
Danielle Rodin, MD, MPH, FRCPC,* ,y and Jose G. Bazan, MD, MS
doi : 10.1016/j.ijrobp.2023.07.021
Volume 117, Issue 4, 15 November 2023, Pages 779-782
Uncinate Uneasiness: A Neuroendocrine Tumor at the Uncinate Process With Interval Growth Is There a Role for Hypofractionated Radiation Therapy?
Emma Maria Dunne, MBBS, PhD, and Veronika Killow, MD
doi : 10.1016/j.ijrobp.2022.12.014
Volume 117, Issue 4, 15 November 2023, Pages 783-784
Radiating the “Radio-Resistant�: The Misunderstood Story of Neuroendocrine Tumors and Radiation
Jonathan M. Loree, MD
doi : 10.1016/j.ijrobp.2023.01.039
Volume 117, Issue 4, 15 November 2023, Page 785
Not for NEN? Role of External Beam Radiation for Neuroendocrine Neoplasms
Sten Myrehaug, MD, FRCPC Sylvia Ng, MD, PhD, FRCPC Julie Hallet, MD, MSc, FRCSC Simron Singh, MD, MPH, FRCPC
doi : 10.1016/j.ijrobp.2023.02.038
Volume 117, Issue 4, 15 November 2023, Pages 785-786
No Regrets About SABR for NETs
Alex R. Ritter, MD Eric D. Miller, MD, PhD
doi : 10.1016/j.ijrobp.2023.08.050
Volume 117, Issue 4, 15 November 2023, Page 786
What Are We Palliating and Why? Don't Just Do Something, Stand There!
Ted K. Yanagihara, MD, PhD
doi : 10.1016/j.ijrobp.2023.08.041
Volume 117, Issue 4, 15 November 2023, Pages 786-787
How Can We Deliver Evidence-Based and Person-Centered Cancer Care for the Transgender Community?
Alison May Berner, MBBS, MSc, PhD, MRCP*
doi : 10.1016/j.ijrobp.2023.06.247
Volume 117, Issue 4, 15 November 2023, Pages 788-790
Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 Trial
Thomas Zilli, MD,*,y,z Sandra Jorcano, MD,x Samuel Bral, MD,? Zvi Symon, MD,{ Carmen Rubio, MD, PhD,# Anna M.E. Bruynzeel, MD, PhD,** Roman Ibrahimov, MD,yy Heikki Minn, MD, PhD,zz Angelo Oliveira, MD,xx Aur elie Bertaut, MSc,?? Guillaume Constantin, MSc,?? and Raymond Miralbell, MD
doi : 10.1016/j.ijrobp.2023.03.057
Volume 117, Issue 4, 15 November 2023, Pages 791-798
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Parag Jitendra Parikh, BSE, MD,* Percy Lee, MD,y Daniel A. Low, PhD,z Joshua Kim, PhD,* Kathryn E. Mittauer, PhD,x Michael F. Bassetti, MD, PhD,? Carri K. Glide-Hurst, PhD,? Ann C. Raldow, MD, MPH,{ Yingli Yang, PhD,{ Lorraine Portelance, MD, # Kyle R. Padgett, PhD, # Bassem Zaki, MD,** Rongxiao Zhang, PhD,** Hyun Kim, MD,yy Lauren E. Henke, MD,yy Alex T. Price, MS,yy Joseph D. Mancias, MD, PhD,zz Christopher L. Williams, PhD,zz John Ng, MD,xx Ryan Pennell, PhD,xx M. Raphael Pfeffer, MD,?? Daphne Levin, PhD,?? Adam C. Mueller, MD, PhD,{{ Karen E. Mooney, PhD,{{ Patrick Kelly, MD, PhD,## Amish P. Shah, PhD, ## Luca Boldrini, MD, PhD,*** Lorenzo Placidi, PhD,*** Martin Fuss, MD,yyy and Michael D. Chuong, MD
doi : 10.1016/j.ijrobp.2023.05.023
Volume 117, Issue 4, 15 November 2023, Pages 799-808
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial
Tiantian Gao, MD,*,1 Yong Yang, MD,y,1 Zewei Zhang, MD,* Yuxian Yang, MD,* Shiliang Liu, MD,* ,y Yonghong Hu, MD,*,y Yujia Zhu, MD,*,y Hong Yang, MD,y,z Jianhua Fu, MD,y,z Junye Wang, MD,z Ting Lin, MD,y,z Mian Xi, MD,*,y Qiaoqiao Li, MD,* ,y Mengzhong Liu, MD,*,y and Lei Zhao, MD
doi : 10.1016/j.ijrobp.2023.05.021
Volume 117, Issue 4, 15 November 2023, Pages 809-820
Development and Validation of a Radiomics Model Based on Lymph-Node Regression Grading After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
SiYu Zhang, MS,* Bin Tang, PhD,* MingRong Yu, MS,y Lei He, MS,* Ping Zheng, MD,* ChuanJun Yan, MS,z Jie Li, PhD,* and Qian Peng, MD*
doi : 10.1016/j.ijrobp.2023.05.027
Volume 117, Issue 4, 15 November 2023, Pages 821-833
Dose-Dependent Atrophy in Bilateral Amygdalae and Nuclei After Brain Radiation Therapy and Its Association With Mood and Memory Outcomes on a Longitudinal Clinical Trial
Soumya Unnikrishnan, MD,*,y Roshan Karunamuni, PhD,y Mia A. Salans, MD, MAS,y Suma Gudipati, BA,* ,y Alexander S. Qian, MD,*,y Justin Yu, BS,y Michael Connor, MD,y Minh-Phuong Huynh-Le, MD, MAS,z Michelle D. Tibbs, MD, MAS,y Gretchen Hermann, MD,y Anny Reyes, PhD,x Alena Stasenko, PhD,x Tyler M. Seibert, MD, PhD,y Carrie R. McDonald, PhD,y,x and Jona A. Hattangadi-Gluth, MD
doi : 10.1016/j.ijrobp.2023.05.026
Volume 117, Issue 4, 15 November 2023, Pages 834-845
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes
Robert W. Gao, MD,* Trey C. Mullikin, MD,y Khaled A. Aziz, MD, PhD,* Arslan Afzal, MBBS,* Na L. Smith, MD, PhD,z David M. Routman, MD,* Kimberly R. Gergelis, MD,* William S. Harmsen, MS,x Nicholas B. Remmes, PhD,* Hok Seum Wan Chan Tseung, PhD,* Satomi S. Shiraishi, PhD,* Judy C. Boughey, MD,k Kathryn J. Ruddy, MD,{ Christin A. Harless, MD, # Allison E. Garda, MD,* Mark R. Waddle, MD,* Sean S. Park, MD, PhD,* Dean A. Shumway, MD,* Kimberly S. Corbin, MD,* and Robert W. Mutter, MD*
doi : 10.1016/j.ijrobp.2023.05.036
Volume 117, Issue 4, 15 November 2023, Pages 846-856
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial
Tobias Forster, MD,*,y,z Clara K€ohler, MD,* Melissa Dorn, MD,* Matthias Felix H€afner, PhD,*,y,z Nathalie Arians, PhD,*,y,z Laila K€onig, PhD,*,y,z Semi Ben Harrabi, MD,*,y,z Ingmar Schlampp, MD,*,y,z Fabian Weykamp, MD,*,y,z Eva Meixner, MD,*,y,z Kristin Lang, PhD,*,y,z Vanessa Heinrich, MD,x Nicola Weidner, MD,x Johannes H€using, MD,? Markus Wallwiener, MD,{ Michael Golatta, MD,{ Andr e Hennigs, MD,{ J€org Heil, MD,{ Holger Hof, MD, # David Krug, PhD,*,y,z, ** J€urgen Debus, MD,* ,y,z,yy,zz,xx and Juliane H€orner-Rieber, MD*
doi : 10.1016/j.ijrobp.2023.05.035
Volume 117, Issue 4, 15 November 2023, Pages 857-868
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes
Francesca Holt, MRCP(UK), MB BChir,* Jake Probert, MSc,* Sarah C. Darby, PhD,* Joanne S. Haviland, MSc,y Charlotte E. Coles, FRCR, PhD,z Anna M. Kirby, FRCR, MDRes,x Zulian Liu, MBBS, MSc,* David Dodwell, FRCR, MD,* Georgios Ntentas, DPhil,* ,? Frances Duane, FFRRCSI, DPhil,{ and Carolyn Taylor, FRCR, DPhil
doi : 10.1016/j.ijrobp.2023.02.023
Volume 117, Issue 4, 15 November 2023, Pages 869-882
Reduced-Dose Radiation Therapy and Concurrent Paclitaxel Chemotherapy in Lymph Node-Positive Breast Cancer: Long-Term Follow-up of a Single-Institution Prospective Study
Courtney E. Pisano, DO, MS, MPH,* Michael Z. Kharouta, MD,y Eleanor E. Harris, MD,z Robert Shenk, MD,x James Martin, MD,? Cynthia Owusu, MD,? and Janice A. Lyons, MD
doi : 10.1016/j.ijrobp.2023.06.008
Volume 117, Issue 4, 15 November 2023, Pages 883-886
The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional 68Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer
Nicholas W. Bucknell, MBBS (hons),*,y Nicholas Hardcastle, PhD,y,z,x Beverley Woon, MBBS,y,? Lisa Selbie, BSc,* Mathias Bressel, MSc,y,{ Keelan Byrne, MBBS,* Jason Callahan, PhD,y,? Gerard G. Hanna, PhD, # Michael S. Hofman, PhD,y,? David Ball, MD,*,y Tomas Kron, PhD,y,z,x and Shankar Siva, PhDy
doi : 10.1016/j.ijrobp.2023.05.039
Volume 117, Issue 4, 15 November 2023, Pages 887-892
Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma?
Kangpyo Kim, MD,* Yong Chan Ahn, MD, PhD,* Dongryul Oh, MD, PhD,* Jae Myoung Noh, MD, PhD,* Han-Sin Jeong, MD, PhD,y Man Ki Chung, MD, PhD,y Sang Duk Hong, MD, PhD,y and Chung-Hwan Baek, MD, PhDy
doi : 10.1016/j.ijrobp.2023.05.038
Volume 117, Issue 4, 15 November 2023, Pages 893-902
Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem
Eliana Vasquez Osorio, PhD,* Azadeh Abravan, PhD,* Andrew Green, PhD,*,y Marcel van Herk, PhD,* Lip Wai Lee, FRCR,z Deborah Ganderton, MSc,x and Andrew McPartlin, FRCR
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial
Li Xiang, PhD,*,y Jin-Feng Rong, MD,z Xin-Chen, MD,z Xiao-Yue Li, MD,* Yun Zheng, MD,* Pei-Rong Ren, MD,* Sheng Lin, PhD,* Qing-Lian Wen, PhD,* Li-Jia He, MD,* Jian-Wen Zhang, MD,* Chang-Ling Shang, MD,* Hong-Ru Yang, PhD,* Juan Fan, MD,* Hao-Wen Pang, MD,* Jing Zhang, MD,* Bang-Xian Tan, MD,x Ling Zhang, PhD,? Xiao-Bo Du, PhD,{ Shi-Min Wen, MD, # Liang Jiang, PhD,** Gang Qin, PhD,** and Jing-Bo Wu, MD
doi : 10.1016/j.ijrobp.2023.06.001
Volume 117, Issue 4, 15 November 2023, Pages 914-924
Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy
Ezra Hahn, MD,* and Wai Tong Ng, MD
doi : 10.1016/j.ijrobp.2023.06.276
Volume 117, Issue 4, 15 November 2023, Pages 925-927
STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung Injury
Yang Zhang, PhD,* Zongjuan Li, PhD,y Weifeng Hong, PhD,* Shujung Hsu, PhD,* Biao Wang, PhD,* Zhaochong Zeng, MD, PhD,* and Shisuo Du, MD, PhD*
doi : 10.1016/j.ijrobp.2023.05.029
Volume 117, Issue 4, 15 November 2023, Pages 928-941
SUMO1 Modification Stabilizes TET3 Protein and Increases Colorectal Cancer Radiation Therapy Sensitivity
Fengting Liu, MBBS,*,y,1 Ya Ma, MBBS,z,1 Hao Sun, MBBS,* Hui Cai, MBBS,* Xin Liang, MD,x,? Chang Xu, MBBS,* Liqing Du, MBBS,* Yan Wang, MD,* and Qiang Liu, MBBS
doi : 10.1016/j.ijrobp.2023.05.037
Volume 117, Issue 4, 15 November 2023, Pages 942-954
Activation of STING in Response to Partial-Tumor Radiation Exposure
Mickael Mathieu, PhD,* Sadna Budhu, PhD,y Prerna R. Nepali, PhD,* James Russell, PhD,z Simon N. Powell, MD, PhD,* John Humm, PhD,z Joseph O. Deasy, PhD,z and Adriana Haimovitz-Friedman, PhD
doi : 10.1016/j.ijrobp.2023.05.032
Volume 117, Issue 4, 15 November 2023, Pages 955-965
Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma
Jinghua Heng, PhD,* Zhimao Li, MM,* Luxin Liu, PhD,y Zhenyuan Zheng, PhD,*,y,z Yaqi Zheng, MM,* Xiue Xu, MM,* Liandi Liao, MM,* Hongyao Xu, MM,x Hecheng Huang, MM,x Enmin Li, PhD,y and Liyan Xu, PhD
doi : 10.1016/j.ijrobp.2023.05.031
Volume 117, Issue 4, 15 November 2023, Pages 966-978
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma
Yang Yang, MD, PhD,*,y TingTing Feng, MD, PhD,z Xiaojun Fan, MS,x Changchun Wang, MD, PhD,? Youhua Jiang, MD,? Xia Zhou, MD,* ,y Wu’an Bao, MD,*,y Danhong Zhang, MD,*,y Shi Wang, MD,{ Jiangping Yu, MD,{ Yali Tao, MD,{ Ge Song, MD, # Hua Bao, PhD,x Junrong Yan, MS,x Xue Wu, PhD,x Yang Shao, PhD,x Guoqin Qiu, MD,*,y Dan Su, MD,z and Qixun Chen, MD
doi : 10.1016/j.ijrobp.2023.06.005
Volume 117, Issue 4, 15 November 2023, Pages 979-993
Comprehensive Evaluation of a Deep Learning Model for Automatic Organs-at-Risk Segmentation on Heterogeneous Computed Tomography Images for Abdominal Radiation Therapy
Wenjun Liao, MD,* Xiangde Luo, PhD,y,z Yuan He, MD,x Ye Dong, MD,? Churong Li, MD,* Kang Li, PhD,{ Shichuan Zhang, MD,* Shaoting Zhang, PhD,y,z Guotai Wang, PhD,y,z and Jianghong Xiao, PhD
doi : 10.1016/j.ijrobp.2023.05.034
Volume 117, Issue 4, 15 November 2023, Pages 994-1006
Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis
Till Tobias B€ohlen, PhD,* Jean-Fran¸cois Germond, PhD,* Kristoffer Petersson, PhD,y,z Esat Mahmut Ozsahin, MD, PhD,x Fernanda G. Herrera, MD, PhD,x Claude Bailat, PhD,* Fran¸cois Bochud, PhD,* Jean Bourhis, MD, PhD,x Rapha€el Moeckli, PhD,* and Gabriel Adrian, MD, PhD
doi : 10.1016/j.ijrobp.2023.05.045
Volume 117, Issue 4, 15 November 2023, Pages 1007-1017
FLASH Effects Induced by Orthovoltage X-Rays
Devin Miles, PhD,a Daniel Sforza, PhD,a John W. Wong, PhD, a Kathleen Gabrielson, DVM, PhD,b Khaled Aziz, MD, PhD,a Mahadevappa Mahesh, MS, PhD,c Jonathan B. Coulter, PhD,d Ismaeel Siddiqui, BA, a Phuoc T. Tran, MD, PhD, a,e Akila N. Viswanathan, MD, MPH, MSc, a and Mohammad Rezaee, PhD
doi : 10.1016/j.ijrobp.2023.06.006
Volume 117, Issue 4, 15 November 2023, Pages 1018-1027
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody
Ioanna Liatsou, PhD,* Anders Josefsson, PhD,y Jing Yu, PhD,* Zhi Li, PhD,* Kaori Davis, DVM, PhD,z Cory Brayton, DVM,z Hao Wang, PhD,x Robert F. Hobbs, PhD,? and George Sgouros, PhD*
doi : 10.1016/j.ijrobp.2023.06.003
Volume 117, Issue 4, 15 November 2023, Pages 1028-1037
Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920
M. Machtay, 1 P. Torres-Saavedra, 2,3 W.L. Thorstad, 4 P.F. Nguyen-Tan, 5 L.L. Siu, 6 F.C. Holsinger, 7 A.K. El-Naggar, 8 C.H. Chung,9 J. Dorth, 10 N.Y. Lee,11 J. Chan,12 N. Dunlap, 13 V. Bar Ad, 14 W.A. Stokes, 15 A. Chakravarti, 16 D. Sher, 17 S.S.D. Rao, 18 J. Harris, 3 S.S. Yom, 12 and Q.T. Le 19;
doi : 10.1016/j.ijrobp.2023.08.025
Volume 117, Issue 4, 15 November 2023, Page e1
Randomized Controlled Trial of Hypofractionated vs. Normo-fractionated Accelerated Radiation Therapy with or without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO)
S.M. Bentzen, 1 E. Rosenblatt, 2 T. Gupta, 3 J.P. Agarwal, 3 S. Ghosh Laskar, 3 S. Bhasker, 4 A.A. Jacinto,5 P. De Marchi, 5 M. Nagarajan, 6 K. Jabeen, 7 S. Binia, 8 Y. Chansilpa, 9 M. Napoles,10 S. Aguiar, 11 O. Goloubeva, 12 E. Zubizarreta, 2 K. Hopkins, 2 and M. Abdel-Wahab 2
doi : 10.1016/j.ijrobp.2023.08.026
Volume 117, Issue 4, 15 November 2023, Page e2
5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer
N. van As, 1 A. Tree, 1 J. Patel,2 P. Ostler, 3 H. Van Der Voet, 4 D.A. Loblaw, 5 W. Chu,6 D. Ford,7 S. Tolan, 8 S. Jain, 9 J.G. Armstrong, 10,11 P. Camilleri, 12 K. Kancherla, 13 J. Frew, 14 A. Chan,15 O. Naismith, 1 G. Manning, 2 S. Brown, 2 C. Griffin, 2 and E. Hall
doi : 10.1016/j.ijrobp.2023.08.027
Volume 117, Issue 4, 15 November 2023, Pages e2-e3
Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)
V. Gondi, 1 S. Pugh, 2 M.P. Mehta,3 J.S. Wefel, 4 W.A. Tome, 5 A. Sun, 6 G.M. Videtic, 7 B.H. Lok,8 H.A. Yoon,9 J.H. Heinzerling, II 10 A.S. DeNittis, 11 R.C. McGarry,12 K. Devisetty, 13 V. Kundapur, 14 A.J. Wu, 15 R. Paulus, 16 and L.A. Kachnic 17;
doi : 10.1016/j.ijrobp.2023.08.028
Volume 117, Issue 4, 15 November 2023, Page e3
Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy after Implant-Based Reconstruction
J.S. Wong, 1 H. Uno, 2 A. Tramontano, 2 C. Pellegrini, 2 J.R. Bellon, 1 M.D. Cheney, 3 P.H. Hardenbergh, 4 A.Y. Ho, 5 K.C. Horst, 6 J.N. Kim, 7 Volume 117 Number 4 2023 Late-Breaking Abstracts e3 K.L. Leonard, 8 M.S. Moran,9 C.C. Park,10 A. Recht, 11 R. Shiloh, 12 A.G. Taghian, 13 L. Warren, 14 J.L. Wright, 15 Y. Chun, 16 and R.S. Pungli
doi : 10.1016/j.ijrobp.2023.08.029
Volume 117, Issue 4, 15 November 2023, Pages e3-e4
Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup Analysis
S. Sridharan, 1 N. Shore,2,3 B. Venugopal, 4 M. Gleave, 5 U. De Giorgi,6 Y. Tang, 7 G.P. Haas, 8 M. Rosales, 8 F. Zohren, 9 and S.J. Freedland10,11;
doi : 10.1016/j.ijrobp.2023.08.030
Volume 117, Issue 4, 15 November 2023, Pages e4-e5
Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial
D. Bernhardt, 1 R. El Shafie, 2,3 M. Thomas, 4 F. Bozorgmehr, 5 A. Schiele, 2 D. Schmitt,2,3 T. Welzel, 2 P. Thalmann, 6 A. Paul,2 L. K€onig, 2 K. Lang, 2 S. Adeberg, 2,7 S. H€one, 8 F. Weykamp,2 P. Vollmuth, 9 A. Lentz-Hommertgen, 2 C. Jaekel, 10 U. Nestle, 11,12 M. Kieser, 6 J. Debus,13,14 and S. Rieken 2,3
doi : 10.1016/j.ijrobp.2023.08.031
Volume 117, Issue 4, 15 November 2023, Page e5
Acute Toxicity and Efficiency Outcomes in the DARTBOARD Randomized Trial of Daily Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma
D.J. Sher, 1 V. Avkshtol,2 M.H. Lin, 1 R. Hughes,3 J. Wang, 4 M. Dohopolski, 3 J. Van Pelt, 3 C.Y. Liao,3 and D.H. Moon
doi : 10.1016/j.ijrobp.2023.08.032
Volume 117, Issue 4, 15 November 2023, Page e6
Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER-Positive Breast Cancer (AVATAR): A Phase II Prospective Multicenter Trial
S.P. David, 1 S. Siva, 2 M. Bressel, 3 J. Tan, 4 G.G. Hanna, 5 R.K. Alomran, 6 E. Yip, 7 C. Morton,7 M. Edmonds, 7 and M. White
doi : 10.1016/j.ijrobp.2023.08.033
Volume 117, Issue 4, 15 November 2023, Page e6
Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)
A. Kirby, 1,2 C. Griffin,3 L. Finneran, 3 M. Sydenham, 3 A. Alhasso, 4 A.M. Brunt, 5 H. Chan,6 M. Jefford, 7 E. Sawyer, 8 I. Syndikus, 9 Y.M. Tsang,10 D. Wheatley, 11 J. Yarnold, 12 C. Coles, 13 and J. Bliss
doi : 10.1016/j.ijrobp.2023.08.034
Volume 117, Issue 4, 15 November 2023, Page e7
Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer
A.S. Rahimi,1 M. Leitch, 2 B. Dogan,3 P.G. Alluri,1 D. Farr, 2 M. Arbab, 1 S. Seiler, 3 D.W.N. Kim, 4 R. Wooldridge, 2 N. Unni, 5 C.R. Nwachukwu, 1 I. Patel, 5 Y. Zhang, 1 D.D.M. Parsons, 1 A. Nguyen, 2 H.E. Morgan, 6 H.L. McArthur, 5 S. Sahoo,7 and R.D. Timmerman
doi : 10.1016/j.ijrobp.2023.08.035
Volume 117, Issue 4, 15 November 2023, Pages e7-e8
Stereotactic Radiosurgery for 1-10 Brain Metastases Avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 Trial
R. El Shafie, 1,2 D. Bernhardt, 3,4 A. Schiele, 1 T. Welzel, 1 D. Schmitt, 1,2 P. Thalmann, 5 S. Erdem, 1 A. Paul, 1 S.J. Hoene, 1 K. Lang, 1 L. K€onig, 1 F. Weykamp, 1 S. Adeberg,1,6 A. Lentz-Hommertgen, 1 C. Jaekel,1 F. Bozorgmehr, 7,8 M. Thomas, 7,8 M. Kieser, 5 J. Debus, 1 and S. Rieken
doi : 10.1016/j.ijrobp.2023.08.036
Volume 117, Issue 4, 15 November 2023, Page e8
Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection – Results of the ESTRON Randomized Phase 2 Trial
R. El Shafie, 1,2 D. Bernhardt, 3,4 A. Schiele,2 T. Welzel,2 D. Schmitt,1,2 P. Thalmann, 5 S. Erdem, 2 A. Paul, 2 S.J. Hoene, 2 K. Lang, 2 L. K€onig, 2 F. Weykamp,2 S. Adeberg, 2,6 A. Lentz-Hommertgen, 2 C. Jaekel, 2 F. Bozorgmehr, 7,8 M. Thomas, 7,8 M. Kieser,5 J. Debus,2 and S. Rieken
doi : 10.1016/j.ijrobp.2023.08.037
Volume 117, Issue 4, 15 November 2023, Pages e8-e9
Diagnostic CT-Enabled Radiation Therapy (DART): Results of a Randomized Trial for Palliative Radiation Therapy
M. O'Neil, 1 J.M. Laba,2 T. Nguyen, 1 M.I. Lock, 1 C.D. Goodman, 2 E. Huynh, 3 J. Snir,4 V. Munro, 5 J.A. Alce, 5 L. Schrijver, 5 S. Lemay, 5 T. Macdonald, 5 A. Warner, 1 and D.A. Palma
doi : 10.1016/j.ijrobp.2023.08.038
Volume 117, Issue 4, 15 November 2023, Pages e9-e10
